ID Name Structure References (top 5) Molecular Target(s)
1ID:27
1'-ACETOXYCHAVICOL ACETATE

Freqency:
in 1 ingredients:

  • 931

  • Properties
    C13H14O4    234.25





    1:  Nakamura Y, Murakami A, Ohto Y, Torikai K, Tanaka T, Ohigashi H.
    Suppression of tumor promoter-induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor 1'-acetoxychavicol acetate.
    Cancer Res.    impact factor:   8.614
    1998;  58(21): 4832-9

    2:  Moffatt J, Hashimoto M, Kojima A, Kennedy DO, Murakami A, Koshimizu K, Ohigashi H, Matsui-Yuasa I.
    Apoptosis induced by 1'-acetoxychavicol acetate in Ehrlich ascites tumor cells is associated with modulation of polyamine metabolism and caspase-3 activation.
    Carcinogenesis.    impact factor:   4.118
    2000;  21(12): 2151-7

    3:  Kobayashi Y, Nakae D, Akai H, Kishida H, Okajima E, Kitayama W, Denda A, Tsujiuchi T, Murakami A, Koshimizu K, Ohigashi H, Konishi Y.
    Prevention by 1'-acetoxychavicol acetate of the induction but not growth of putative preneoplastic, glutathione S-transferase placental form-positive, focal lesions in the livers of rats fed a choline-deficient, L-amino acid-defined diet.
    Carcinogenesis.    impact factor:   4.118
    1998;  19(10): 1809-14

    4:  Ohata T, Fukuda K, Murakami A, Ohigashi H, Sugimura T, Wakabayashi K.
    Inhibition by 1'-acetoxychavicol acetate of lipopolysaccharide- and interferon-gamma-induced nitric oxide production through suppression of inducible nitric oxide synthase gene expression in RAW264 cells.
    Carcinogenesis.    impact factor:   4.118
    1998;  19(6): 1007-12

    5:  Tanaka T, Makita H, Kawamori T, Kawabata K, Mori H, Murakami A, Satoh K, Hara A, Ohigashi H, Koshimizu K.
    A xanthine oxidase inhibitor 1'-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats.
    Carcinogenesis.    impact factor:   4.118
    1997;  18(5): 1113-8

    DT diaphorase
    ROS
     
    Time used: 485 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005